Search Results - "Seiwald, Maria Cristina"
-
1
Expert Recommendations for the Diagnosis, Treatment, and Management of Adult B-Cell Acute Lymphoblastic Leukemia in Latin America
Published in JCO global oncology (01-05-2023)“…Despite strong induction chemotherapy response rates, only 30%-40% of patients with adult B-cell acute lymphoblastic leukemia (ALL) attain long-term remission…”
Get full text
Journal Article -
2
Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers
Published in Supportive care in cancer (01-12-2023)“…Purpose The prompt initiation of a betalactam antibiotic in febrile neutropenic patients is considered standard of care, while the empiric use of vancomycin is…”
Get full text
Journal Article -
3
Long-Term Follow-up of Ruxolitinib in Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease (GVHD)
Published in Blood (05-11-2020)“…Introduction: Chronic graft-versus-host disease (cGVHD) remains a major barrier to a successful hematopoietic stem cell transplantation (HSCT), associated with…”
Get full text
Journal Article -
4
Increased Risk of for Cytomegalovirus Reactivation after Allogeneic HSCT in T-Cell Depleted Patients
Published in Blood (05-11-2020)“…Background: Reactivation of Cytomegalovirus (CMV) is frequent after allogeneic hematopoietic stem cell transplantation (HSCT), occurring in approximately 70%…”
Get full text
Journal Article -
5
Low Dose Ganciclovir for Cytomegalovirus Reactivation after Allogeneic HSCT Is a Feasible Option with Same Efficacy and Less Toxicity Than Regular Dose
Published in Blood (05-11-2020)“…Background: Cytomegalovirus (CMV) reactivation after allogeneic hematopoietic stem cell transplantation (HSCT) occurs in approximately 70% of seropostive…”
Get full text
Journal Article -
6
Long-Term Follow-Up of Ruxolitinib in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease
Published in Transplantation and cellular therapy (01-09-2021)“…•Ruxolitinib as therapy for steroid-refractory chronic graft-versus-host disease is associated with high rates of overall response.•Long-term follow-up…”
Get full text
Journal Article